Summit Global Investments
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1697953
BOUNTIFUL, UT
Position in VRTX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,567,514
+$1,827,795 QoQ
Shares Held
7,182
+84.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#542
of 1,732 holders
Holding Since
Jun 2020
24 quarters on record
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Summit Global Investments holds $20,708,446 across 14 Biotechnology names. VRTX ranks #3 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
55,370 | $6,276,743 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,506 | $4,680,291 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
7,182 | $3,567,514 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
32,667 | $1,869,205 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
27,034 | $984,307 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
2,167 | $805,408 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
7,542 | $615,200 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,937 | $612,266 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,567,514 | 7,182 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,739,719 | 3,896 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,905,925 | 4,204 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $1,948,017 | 4,974 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,741,622 | 3,912 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,730,807 | 3,570 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $2,004,237 | 4,977 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,692,813 | 5,790 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $4,508,617 | 9,619 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $17,518,381 | 41,909 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $30,349,111 | 74,588 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $17,898,177 | 51,470 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $18,096,619 | 51,424 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $21,633,336 | 68,662 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $19,749,375 | 68,389 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $21,138,736 | 73,008 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $22,782,439 | 80,849 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $23,633,965 | 90,562 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $20,871,662 | 95,044 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $1,009,561 | 5,007 | Shares | Sole | 2022-01-28 | |
| 2021-03-31 | $10,842,060 | 50,454 | Shares | Sole | 2022-01-27 | |
| 2020-12-31 | $7,042,222 | 29,797 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $562,199 | 2,066 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $605,006 | 2,084 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||